NASDAQ: LBRXRUSSELL2000
LB Pharmaceuticals Inc Common Stock
Healthcare · Biotechnology · Headquartered in New York, US
Price
Loading chart…
Overview
This biopharmaceutical firm is currently in the clinical development stage, concentrating on the creation of innovative treatments for neuropsychiatric disorders such as schizophrenia and bipolar depression. Central to their pipeline is LB-102, their primary investigational drug, which is a methylated variant of amisulpride.
History & business model
This section is waiting to be written.
InvestWiki is community-edited. Contribute a plain-English history of LB Pharmaceuticals Inc Common Stock, its business model, key products, and controversies.